{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:29:10Z","timestamp":1781332150435,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178241","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:34:15Z","timestamp":1760196855000},"page":"178241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Asparagine synthetase promoter hypermethylation is required, but not sufficient, for sensitivity to Asparlas in patient-derived models of hepatocellular carcinoma"],"prefix":"10.1016","volume":"1007","author":[{"given":"Ethika","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Pohorecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Valour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Neau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-5316","authenticated-orcid":false,"given":"Pierre","family":"Barbier Saint Hilaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Studeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Moulharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Darville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eef","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178241_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/bloodadvances.2021004271","article-title":"Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL","volume":"6","author":"Akahane","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.ejphar.2025.178241_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.celrep.2013.12.041","article-title":"Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity","volume":"6","author":"Almendro","year":"2014","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178241_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/acsptsci.0c00196","article-title":"Therapeutic assessment of targeting ASNS combined with l-Asparaginase treatment in solid tumors and investigation of resistance mechanisms","volume":"4","author":"Apfel","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2025.178241_bib4","doi-asserted-by":"crossref","first-page":"E789","DOI":"10.1152\/ajpendo.00015.2013","article-title":"Asparagine synthetase: regulation by cell stress and involvement in tumor biology","volume":"304","author":"Balasubramanian","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178241_bib5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1084\/jem.127.6.1055","volume":"127","author":"Broome","year":"1968","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178241_bib6","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3389\/fonc.2019.01480","article-title":"Asparagine synthetase in cancer: beyond acute lymphoblastic leukemia","volume":"9","author":"Chiu","year":"2019","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.ejphar.2025.178241_bib7","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/bloodadvances.2020004041","article-title":"ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment","volume":"5","author":"Chiu","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ejphar.2025.178241_bib8","first-page":"2368","article-title":"Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis","volume":"60","author":"Esteller","year":"2000","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178241_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/nu17010179","article-title":"Targeting asparagine metabolism in solid tumors","volume":"17","author":"Hanada","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2025.178241_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178241_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2025.178241_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbm.2023.100014","article-title":"Patient-derived tumor models and their distinctive applications in personalized drug therapy","volume":"1","author":"He","year":"2023","journal-title":"Mechanobiol. Med."},{"key":"10.1016\/j.ejphar.2025.178241_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.exphem.2012.04.005","article-title":"Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase","volume":"40","author":"Hermanova","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ejphar.2025.178241_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178241_bib15","doi-asserted-by":"crossref","first-page":"18674","DOI":"10.1074\/jbc.RA119.010447","article-title":"Promoter demethylation of the asparagine synthetase gene is required for ATF4-dependent adaptation to asparagine depletion","volume":"294","author":"Jiang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178241_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/5947","article-title":"Cancer-epigenetics comes of age","volume":"21","author":"Jones","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2025.178241_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer","volume":"3","author":"Jones","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejphar.2025.178241_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ejphar.2025.178241_bib19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.178241_bib20","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1535-7163.MCT-06-0447","article-title":"Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells","volume":"5","author":"Lorenzi","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2025.178241_bib21","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.18632\/oncotarget.7067","article-title":"Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival","volume":"7","author":"Morris","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2025.178241_bib22","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.3390\/cells11203273","article-title":"Targeting asparagine synthetase in tumorgenicity using patient-derived tumor-initiating cells","volume":"11","author":"Nishikawa","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.178241_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trsl.2022.08.003","article-title":"Next generation patient derived tumor organoids","volume":"250","author":"Podaza","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejphar.2025.178241_bib24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0003-9861(68)90273-7","article-title":"Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase","volume":"127","author":"Prager","year":"1968","journal-title":"Arch. Biochem. Biophys."},{"issue":"35","key":"10.1016\/j.ejphar.2025.178241_bib25","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/acs.biochem.0c00354","article-title":"Improving the treatment of acute lymphoblastic leukemia","volume":"59","author":"Radadiya","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2025.178241_bib26","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4161\/cc.8.19.9626","article-title":"Exploiting synthetic lethal interactions for targeted cancer therapy","volume":"8","author":"Reinhardt","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2025.178241_bib27","article-title":"PDX: moving beyond drug screening to versatile models for research discovery","volume":"4","author":"Risbridger","year":"2020","journal-title":"J. Endo. Soc."},{"key":"10.1016\/j.ejphar.2025.178241_bib28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1600-0463.2007.apm_689a.x","article-title":"Heterotransplantation of a human malignant tumour to \u201cnude\u201d mice. 1969","volume":"115","author":"Rygaard","year":"2007","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.ejphar.2025.178241_bib29","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1080\/10428194.2018.1542146","article-title":"Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on children's oncology group AALL07P4","volume":"60","author":"Schore","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.ejphar.2025.178241_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/pbc.21213","article-title":"Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines","volume":"50","author":"Su","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejphar.2025.178241_bib31","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1078-0432.CCR-18-1844","article-title":"Epigenetic silencing affects l-Asparaginase sensitivity and predicts outcome in T-ALL","volume":"25","author":"Touzart","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178241_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3324\/haematol.2015.137380","article-title":"Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation","volume":"101","author":"van der Sluis","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2025.178241_bib33","article-title":"A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models","volume":"611","author":"Van Trimpont","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2025.178241_bib34","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood.2019004090","article-title":"Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL","volume":"136","author":"Watanabe","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2025.178241_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2268814","article-title":"Utility of ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL","volume":"18","author":"Watanabe","year":"2023","journal-title":"Epigenetics"},{"key":"10.1016\/j.ejphar.2025.178241_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12964-024-01540-x","article-title":"Metabolism of asparagine in the physiological state and cancer","volume":"22","author":"Yuan","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2025.178241_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbabio.2016.12.003","article-title":"Metabolic synthetic lethality in cancer therapy","volume":"1858","author":"Zecchini","year":"2017","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.ejphar.2025.178241_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/bjc.2013.293","article-title":"Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma","volume":"109","author":"Zhang","year":"2013","journal-title":"Br. J. Cancer"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:27:33Z","timestamp":1779323253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925009951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"alternative-id":["S0014299925009951"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178241","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asparagine synthetase promoter hypermethylation is required, but not sufficient, for sensitivity to Asparlas in patient-derived models of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178241"}}